Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
Date
News Topics
- (-) Biology (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (2)
- Biomedical (3)
- Buildings (1)
- Chemical Sciences (7)
- Clean Water (2)
- Composites (2)
- Computer Science (9)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (6)
- Environment (6)
- Exascale Computing (1)
- Fusion (2)
- Grid (2)
- High-Performance Computing (2)
- Isotopes (6)
- Machine Learning (2)
- Materials (19)
- Materials Science (17)
- Mathematics (1)
- Microscopy (6)
- Nanotechnology (8)
- Neutron Science (10)
- Nuclear Energy (9)
- Partnerships (3)
- Physics (11)
- Polymers (4)
- Quantum Computing (1)
- Security (1)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (2)
- Transformational Challenge Reactor (2)
- Transportation (4)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.